1-11 of 11
Wanling Xie
Close
Sort by
Journal Articles

Time to Development of Treatment-Emergent Extramedullary and Osseous Plasmacytomas in the Era of Novel Agents: An Analysis of Upfront Regimens in Newly Diagnosed MM Incorporating Lenalidomide and Bortezomib

Cindy Varga, Jacob P. Laubach, MD, Irene M. Ghobrial, MD, Matthew Weinstock, MD, Claudia E. Paba-Prada, MD, Robert L. Schlossman, MD, Nikhil Munshi, Wanling Xie, MS, Edie A. Weller, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD PhD, Paul G. Richardson
Journal: Blood
Blood (2014) 124 (21): 3468.
https://doi.org/10.1182/blood.V124.21.3468.3468
Published: 2014
Journal Articles

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

Clinical Trials & Observations
Paul G. Richardson, Wanling Xie, Sundar Jagannath, Andrzej Jakubowiak, Sagar Lonial, Noopur S. Raje, Melissa Alsina, Irene M. Ghobrial, Robert L. Schlossman, Nikhil C. Munshi, Amitabha Mazumder, David H. Vesole, Jonathan L. Kaufman, Kathleen Colson, Mary McKenney, Laura E. Lunde, John Feather, Michelle E. Maglio, Diane Warren, Dixil Francis, Teru Hideshima, Robert Knight, Dixie-Lee Esseltine, Constantine S. Mitsiades, Edie Weller, Kenneth C. Anderson
Journal: Blood
Blood (2014) 123 (10): 1461–1469.
https://doi.org/10.1182/blood-2013-07-517276
Published: 2014
Journal Articles

Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution

Houry Leblebjian, PharmD, BCOP, Wanling Xie, MS, Paul G. Richardson, MD, Irene M. Ghobrial, MD, Christy Harris, PharmD, BCPS, BCOP, Robert L Schlossman, MD, Claudia E. Paba-Prada, MD, Nikhil C. Munshi, MD, Sylvia Bartel, R.Ph., M.H.P., Kenneth C. Anderson, MD, Edie A. Weller, PhD, Jacob P. Laubach, MD
Journal: Blood
Blood (2013) 122 (21): 1977.
https://doi.org/10.1182/blood.V122.21.1977.1977
Published: 2013
Journal Articles

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

Clinical Trials & Observations
Gilles Salles, Daphne de Jong, Wanling Xie, Andreas Rosenwald, Mukesh Chhanabhai, Philippe Gaulard, Wolfram Klapper, Maria Calaminici, Birgitta Sander, Christoph Thorns, Elias Campo, Thierry Molina, Abigail Lee, Michael Pfreundschuh, Sandra Horning, Andrew Lister, Laurie H. Sehn, John Raemaekers, Anton Hagenbeek, Randy D. Gascoyne, Edie Weller
Journal: Blood
Blood (2011) 117 (26): 7070–7078.
https://doi.org/10.1182/blood-2011-04-345256
Published: 2011
Includes: Supplemental data
Journal Articles

The Role of Serum Immunoglobulin Free Light Chain In Response and Progression In Waldenstrom Macroglobulinemia

Xavier Leleu, MD, PhD, Wanling Xie, MS, Meghan Rourke, Ranjit Banwait, Renee Leduc, Nitin Roper, Edie Weller, Irene Ghobrial, MD
Journal: Blood
Blood (2010) 116 (21): 3095.
https://doi.org/10.1182/blood.V116.21.3095.3095
Published: 2010
Journal Articles

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial, Andrzej J. Jakubowiak, Sundar Jagannath, Noopur S. Raje, David E. Avigan, Wanling Xie, Irene M. Ghobrial, Robert L. Schlossman, Amitabha Mazumder, Nikhil C. Munshi, David H. Vesole, Robin Joyce, Jonathan L. Kaufman, Deborah Doss, Diane L. Warren, Laura E. Lunde, Sarah Kaster, Carol DeLaney, Teru Hideshima, Constantine S. Mitsiades, Robert Knight, Dixie-Lee Esseltine, Kenneth C. Anderson
Journal: Blood
Blood (2010) 116 (5): 679–686.
https://doi.org/10.1182/blood-2010-02-268862
Published: 2010
Journal Articles

Molecular Sequaele of Activin A-Dependent Osteoblast Inhibition in Myeloma.

Sonia Vallet, MD., Siddhartha Mukherjee, M.D., Nileshwari Vaghela, Teru Hideshima, M.D., Ph.D., Mariateresa Fulciniti, PhD, Samantha Pozzi, MD, Loredana Santo, Diana Cirstea, MD, Aliyah Rahemtullah, MD, Eyal C. Attar, MD, Alexander R Guimaraes, Dharminder Chauhan, Ph.D, Wanling Xie, Chirayu Patel, Jesse Schoonmaker, Michael Churchill, Kishan Patel, Edie Weller, PhD, Nikhil C. Munshi, Jasbir Seehra, Kenneth C. Anderson, MD, David T. Scadden, MD, Noopur Raje, MD.
Journal: Blood
Blood (2009) 114 (22): 1789.
https://doi.org/10.1182/blood.V114.22.1789.1789
Published: 2009
Journal Articles

High Response Rates and Encouraging Time-to-Event Data with Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Final Results of a Phase I/II Study.

Paul G Richardson, Sagar Lonial, Andrzej J Jakubowiak, Sundar Jagannath, Noopur S Raje, David E Avigan, Irene Ghobrial, Robert L Schlossman, Amitabha Mazumder, Nikhil C. Munshi, Jacob Laubach, David Vesole, Robin Joyce, Jacalyn Rosenblatt, Wanling Xie, Deborah Doss, Diane L. Warren, Kate Ittleman, Carolyn Revta, Dixil Francis, Charles Leister, Sarah Kaster, Carol Delaney, Marisa Lauria, Constantine S. Mitsiades, Teru Hideshima, Robert Knight, Dixie-Lee Esseltine, Edie Weller, Kenneth C. Anderson
Journal: Blood
Blood (2009) 114 (22): 1218.
https://doi.org/10.1182/blood.V114.22.1218.1218
Published: 2009
Journal Articles

Final Results of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed and/or Refractory Waldenstrom Macroglobulinemia (WM).

Irene M. Ghobrial, M.D., Xavier Leleu, MD, PhD, Nancy Rubin, MD, Wanling Xie, Fangxin Hong, Stacey Chuma, RN, Renee Leduc, Marybeth Nelson, PA, Kelly O’Connor, Amy Sam, Brianna Harris, Diane Warren, Peter Sportelli, Steven P. Treon, MD, PhD, Edie Weller, PhD, Kenneth C. Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2008) 112 (11): 1010.
https://doi.org/10.1182/blood.V112.11.1010.1010
Published: 2008
Journal Articles

Restoration of Bone Balance Via Activin a Inhibition Results in Anti-Myeloma Activity

Sonia Vallet, MD, Siddhartha Mukherjee, MD, Nileshwari Vaghela, MS, Samantha Pozzi, MD, Loredana Santo, MD, Diana Cirstea, MD, Mariateresa Fulciniti, PhD, Aliyah Rahemtullah, MD, Eyal Attar, MD, Alexander R Guimaraes, Wanling Xie, Chirayu Patel, Jesse Schoonmaker, Edie Weller, PhD, Teru Hideshima, M.D., Ph.D., Nikhil C. Munshi, MD, Jas Seehra, David T. Scadden, MD, Kenneth C Anderson, MD, Noopur Raje, MD
Journal: Blood
Blood (2008) 112 (11): 645.
https://doi.org/10.1182/blood.V112.11.645.645
Published: 2008
Journal Articles

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Yu-Tzu Tai, Myles Dillon, Weihua Song, Merav Leiba, Xian-Feng Li, Peter Burger, Alfred I. Lee, Klaus Podar, Teru Hideshima, Audie G. Rice, Anne van Abbema, Lynne Jesaitis, Ingrid Caras, Debbie Law, Edie Weller, Wanling Xie, Paul Richardson, Nikhil C. Munshi, Claire Mathiot, Hervé Avet-Loiseau, Daniel E. H. Afar, Kenneth C. Anderson
Journal: Blood
Blood (2008) 112 (4): 1329–1337.
https://doi.org/10.1182/blood-2007-08-107292
Published: 2008
Includes: Supplemental data